483 Cangene BioPharma. dba Emergent BioSolutions Feb 2019

483 Cangene BioPharma. dba Emergent BioSolutions Feb 2019

Debra Emerson FDA$119.00 - Available Now

FDA investigators audited the Cangene BioPharma. dba Emergent BioSolutions - Rockville, MD, United States facility and issued inspectional observations (via FDA 483) on 16 Feb 2019.

Product details

  • Category: Biologics
  • Inspection end: 16 Feb 2019
  • Location: Rockville, United States
  • FEI: 3008934776
Add To Cart